In Vivo Investigation of 6 Membranes Including Their Physical, Chemical and Biological Properties.
In Vivo Investigation of Six Different Membranes Including Their Physical, Chemical and Biological Properties - a Pilot Study.
1 other identifier
interventional
24
1 country
1
Brief Summary
A wide range of resorbable and non-resorbable membranes have been investigated over the last decades. Barrier membranes protect bone defects from ingrowth of soft tissue cells, provide mechanical stability of the defect area and allow bone progenitor cells to develop within a blood clot that is formed beneath the barrier membrane, taking a minimum of four to six weeks for periodontal tissues and 16-24 weeks for bone1,2.These membranes are utilized to reconstruct bone defects prior to implantation and to cover dehiscences and fenestrations around dental implants. When aiming to regenerate bone, resorbable or a non - resorbable membranes should be selected depending on location, size and defect area. However, until now the ideal membrane has not been described due to different opinions between authors3,4. Nevertheless, an ideal membrane should maintain its barrier function enough time for new bone formation, and if possible should be resorbable, so that a second surgical procedure for the explantation of the membrane would not be required, thus reducing the morbidity5. However, the use of a barrier membrane is a technique-sensitive procedure that is not free of complications. The main cause of Guided Bone Regeneration (GBR) failure is related to early or late exposure of the membrane, leading to contamination and infection of the biomaterial, irreversibly compromising bone regeneration4,6,7. Consequently, the inflammatory reaction of the surrounding soft tissues may require early removal of the membrane. Other complications, such as the onset of an abscess with purulent exudate, can also lead to a complete failure of GBR even without exposure of the membrane. It is thought necessary to perform this clinical study due to the lack of information present in the literature about the different types of membranes that exist nowadays, how they act in the human body with or without performing some type of regeneration and how our body acts towards them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 18, 2022
CompletedFirst Posted
Study publicly available on registry
July 5, 2022
CompletedJuly 5, 2022
June 1, 2022
1.9 years
March 18, 2022
June 29, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Grade of the biocompatibility of the biomaterials
The grade of biocompatibility will be assessed by using histology tools, analyzing the type of cells present in the sample.
Outcome will be measured once, after samples are collected and processed, 2-3 months after implantation.
Characteristics of the inmune response of the biomaterials in the host tissues
The characteristics of the inmune response will be assessed by using histology tools, determining the presence of inflammatory cells such as macrophages.
Outcome will be measured once, after samples are collected and processed, 2-3 months after implantation.
Rate of degradation of the biomaterials
The rate of degradation of the biomaterials will be assessed by using histology tools, analyzing the amount of biomaterial present in the samples and comparing it to the amount that was implanted.
Outcome will be measured once, after samples are collected and processed, 2-3 months after implantation.
Study Arms (6)
Study group biomaterial 1
EXPERIMENTALStudy group biomaterial 2
EXPERIMENTALStudy group biomaterial 3
EXPERIMENTALStudy group biomaterial 4
EXPERIMENTALStudy group biomaterial 5
EXPERIMENTALStudy group biomaterial 6
EXPERIMENTALInterventions
Implant a approved biomaterial by European Regulatory Agencies
Eligibility Criteria
You may qualify if:
- Overall, healthy patients that qualify for oral surgery (ASA I and II)
- Older than 18 years old
- Requiring extraction of 1-3 teeth (premolars or molars) that do not involve the aesthetic area
- Stable post-extraction socket walls with at least 4 walls
- Patient candidate to an early implant placement in the extraction area
- Informed consent signed
- Adequate oral hygiene: plaque index \< 25% before the surgery
- Smoker of \<10 cigarettes per day
- Able to follow the instructions and able to meet the follow-ups
- Healthy or controlled periodontal disease
You may not qualify if:
- Patients who not agree with informed consent
- Untreated periodontal disease
- Presence of dehiscence and/or fenestration at buccal plate of the extraction teeth
- Patient who will need GBR or Block Regeneration
- after the extraction
- History of head and/or neck radiation
- History of chemotherapy in the five years prior of the surgery
- Non controlled Diabetes
- Chronic corticoids or other medication that may influence healing and / or osseointegration
- Smoker of \>10 cigars per day
- Alcohol or other drugs abuse
- Patient going under bisphosphonates treatment or taking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UIC Barcelona
Barcelona, Spain
Study Officials
- PRINCIPAL INVESTIGATOR
Jordi Caball, DDS MSc PhD
UIC Barcelona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 18, 2022
First Posted
July 5, 2022
Study Start
September 15, 2019
Primary Completion
July 30, 2021
Study Completion
March 1, 2022
Last Updated
July 5, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share